Table 6.

Comparison of OxLDL, 8-OHdG, MDA, total antioxidant status, MDA/TAS in relation to autoantibody status

	Autoantibody positive	Autoantibody negative	p
OxLDL*
SSA (N = 53) OxLDL	23 2207.46 (503–17665)	30 2167.00 (905–28752)	0.733
SSB (N = 53) OxLDL	7 2586.55 (1192–17665)	46 2166.68 (503–28752)	0.813
Sm (N = 53) OxLDL	15 1797.63 (503–17703)	38 2253.28 (906–28752)	0.236
Nucleosome (N = 53) OxLDL	23 2119.42 (503–17703)	30 2253.28 (905–28752)	0.720
ds-DNA (N = 66) OxLDL	47 2785.06 (503–28650)	19 2119.42 (671–27103)	0.388
8-OHdG*
SSA (N = 53) 8-OHdG	23 17.57 (0–241)	30 18.73 (13–344)	0.518
SSB (N = 53) 8-OHdG	7 19.6 (13–241)	46 18.56 (0–344)	0.563
Sm (N = 53) 8-OHdG	15 17.51 (0–344)	38 18.64 (0–304)	0.441
Nucleosome (N = 53) 8-OHdG	23 19.6 (0–344)	30 18.43 (0–304)	0.647
ds—DNA (N = 66) 8-OHdG	47 19.60 (0–725)	19 18.79 (16–142)	0.804
MDA*
SSA (N = 53) MDA	23 2.49 (1–8)	30 2.21 (1–8)	0.49
SSB (N = 53) MDA	7 3.08 (2–8)	46 2.23 (1–8)	0.134
Sm (N = 53) MDA	15 2.23 (1–8)	38 2.41 (1–8)	0.790
Nucleosome (N = 53) MDA	23 2.23 (1–8)	30 2.41 (1–8)	0.936
ds-DNA (N = 66) MDA	47 2.53 (1–8)	19 1.93 (1–5)	0.003
TAS*
SSA (N = 53) TAS	23 14.48 (0–18)	30 13.30 (0–18)	0.666
SSB (N = 53) TAS	7 7.10 (0–15)	46 14.36 (0–18)	0.012
Sm (N = 53) TAS	15 13.23 (0–18)	38 14.42 (0–18)	0.244
Nucleosome (N = 53) TAS	23 14.35 (0–18)	30 13.30 (0–18)	0.986
ds-DNA (N = 66) TAS	47 12.9 (0–18)	19 17.22 (0–18)	0.004
MDA/TAS*
SSA (N = 53) MDA/TAS	23 0.20 (0.05–7.89)	30 0.22 (0.05–4.75)	0.97
SSB (N = 53) MDA/TAS	7 0.43 (0.14–7.60)	46 0.17 (0.05–7.8)	0.026
Sm (N = 53) MDA/TAS	15 0.17 (0.05–7.89)	38 0.21 (0.05–7.60)	0.95
Nucleosome (N = 53) MDA/TAS	23 0.17 (0.06–4.75)	30 0.24 (0.05–7.89)	0.97
ds-DNA (N = 66) MDA/TAS	47 0.27 (0.05–7.89)	19 0.12 (0.05–2.24)	0.06

OxLDL oxidised LDL, 8-OHdG 8-hydroxy-2′-deoxyguanosine, MDA malonaldehyde, TAS total antioxidant status

Units of measurements—OxLDL is in ng/L, 8-OHdG is ng/ml, MDA is μM, TAS is U/mL

*All values are median (IQR)